Company Filing History:
4 out of 167 
1 out of 822 
Years Active: 2015-2018
Title: Hannes Koolman: Innovator in Pharmaceutical Chemistry
Introduction
Hannes Koolman is a notable inventor based in North Chicago, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of innovative compounds that have potential therapeutic applications.
Latest Patents
One of Hannes Koolman's latest patents involves tricyclic quinoline and quinoxaline derivatives. This invention relates to pharmaceutical compositions containing these compounds, which serve as modulators, particularly as agonists or partial agonists of the 5-HT receptor. The patent outlines their use in preparing medicaments for the prevention or treatment of various conditions and disorders that respond to the modulation of the 5-HT receptor. This innovative approach has the potential to impact the treatment landscape for several medical conditions.
Career Highlights
Throughout his career, Hannes Koolman has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Hannes has collaborated with several esteemed colleagues, including Wilfried Martin Braje and Helmut Mack. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Hannes Koolman is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the area of tricyclic quinoline and quinoxaline derivatives, demonstrate his commitment to advancing medical science.